Evidence map›Paper›PMID 29901239›Full record

ArticleJournal of evaluation in clinical practice2018

The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV

Zhe Hui Hoo, Rachael Curley, Michael J Campbell, Stephen J Walters, Martin J Wildman

Abstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhe Hui HooSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-7067-3783
Rachael CurleySchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Michael J CampbellSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Stephen J WaltersSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Martin J WildmanSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

Funding

Department of Health DRF-2014-07-092
6 · The paper itself

Abstract

RATIONALE, AIMS AND

objectiveCross-country comparisons of cystic fibrosis (CF) outcomes can potentially identify variation in care but are dependent on data quality. An important assumption is that the UK annual review FEV

methodProspective encounter-based data collected in Sheffield (n = 174) was used to establish whether annual review FEV

resultsSheffield results showed a group-level discrepancy between best and annual review FEV

conclusionsAnnual review FEV

Indexed as

Cystic FibrosisData AccuracyForced Expiratory VolumeAdultFemaleHumansMaleObserver VariationOutcome Assessment, Health CarePatient AcuityPatient CareRegistriesUnited Kingdomclinical epidemiologycystic fibrosisrespiratory measurement

Identifiers

PMID29901239
PMCPMC6099433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.